Labcorp Holdings Inc.
One of the world's largest medical testing companies, Labcorp runs thousands of patient service centers and supports drug development trials for biopharma clients around the globe, offering everything from routine blood work to oncology and prenatal screening. It began in 1969, when three brothers—the Powells—started testing specimens in the former laundry room of a North Carolina hospital; that lab merged with National Health Laboratories in 1995 to create today's company.
Granted 58.5K · Sold 14.6K
Granted 11.3K
Granted 12.3K
Granted 4.0K
Granted 1.6K
Granted 6.4K
Granted 1.2K
Granted 6.6K
Granted 1.3K
Granted 1.6K · Sold 762
Granted 2.4K · Sold 839
Granted 2.4K · Sold 1.6K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Schechter Adam HPresident & CEO, Director · 4 transactions | +22.8% | 107.2K | 58.5K | — | 14.6K |
| Caveney Brian JEVP, Pres of ED, CMO & CSO · 4 transactions | +21.2% | 36.5K | 11.3K | — | — |
| Schroeder Mark SEVP, Pres Diagnostics & COO · 4 transactions | +143.7% | 15.8K | 12.3K | — | — |
| Summy Amy B.EVP, Chief Marketing Officer · 2 transactions | +35.7% | 7.9K | 4.0K | — | — |
| Vaughn Bryan TEVP, Diagnostics · 2 transactions | +20.2% | 6.7K | 1.6K | — | — |
| van der Vaart Sandra DEVP, Corporate Affairs · 2 transactions | +141.9% | 6.2K | 6.4K | — | — |
| Bailey Megan D.EVP, Pres, Central Labs & Intl · 2 transactions | +28.5% | 5.3K | 1.2K | — | — |
| Graham Anita ZEVP, CHRO · 2 transactions | +255.1% | 5.2K | 6.6K | — | — |
| Oyegunwa AkinboladeEVP, CIO & CTO · 2 transactions | +21.3% | 5.1K | 1.3K | — | — |
| Kyle Kathryn WEVP, Chief Legal Officer · 3 transactions | +10.8% | 3.8K | 1.6K | — | 762 |
| Meltzer Jonathan CEVP, Operations · 3 transactions | +30.1% | 3.6K | 2.4K | — | 839 |
| Wilkinson Peter JSVP, Chief Accounting Officer · 3 transactions | 0% | 1.9K | 2.4K | — | 1.6K |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last 6 months: -17.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.